Skip to main content
. Author manuscript; available in PMC: 2013 Mar 18.
Published in final edited form as: Arch Pediatr Adolesc Med. 2011 Mar;165(3):262–268. doi: 10.1001/archpediatrics.2011.1

Table 2.

Primary Study Outcomes

Outcome Treatment Group
(n=260)
Control Group
(n=263)
Difference (95% CI)
or RR (95% CI)a
P Valuea
Symptoms in peak winter season, November-February, mean (SD)
 Symptom-free days/2 wk 11.6 (2.5) 10.7 (3.1) 0.92 (0.50 to 1.33)b <.001
 Symptom nights/2 wk 1.7 (2.2) 2.3 (2.5) −0.68 (−1.01 to −0.35)b <.001
 Days with activity limitation/2 wk 1.3 (2.0) 1.8 (2.3) −0.47 (−0.78 to −0.16)b .003
 Days with rescue medication use/2 wk 1.6 (2.2) 2.6 (2.7) −1.06 (−1.41 to −0.72)b <.001
 Days absent due to asthma/2 wk 0.3 (0.7) 0.5 (0.7) −0.17 (−0.28 to −0.06)b .002
Visits for asthma, No. (%)c
 Emergency department visit 13 (5) 19 (7) 0.60 (0.28 to 1.30)d .20
 Acute office visit 23 (9) 33 (12) 0.74 (0.44 to 1.22)d .23
 Hospitalization 0 2 (1) NA .67e
 Acute exacerbationf 31 (12) 49 (18) 0.64 (0.41 to 1.00)d .05

Abbreviations: CI, confidence interval; NA, not applicable; RR, relative risk.

a

Results of the multivariate analysis are adjusted for baseline symptoms, child’s age, sex, race, caregiver’s education, insurance, maternal depression, and smoke exposure.

b

Values are expressed as difference (95% CI).

c

Defined as a visit to the emergency department, office, or hospital where prednisone was prescribed, during the entire study period (n=525).

d

Values are expressed as RR (95% CI).

e

Estimate is from exact logistic regression.

f

Any visit for asthma where prednisone was prescribed.